A survey has been launched on the Internet across Europel to gather information on the factors that influence the prescribing practices of veterinarians concerning antimicrobials. Practicing veterinary surgeons are encouraged to complete this survey which closes on April 15th 2012.
The European Medicines Agency confirms that the benefit / risk balance of strontium ranelate (PROTELOS in Belgium) remains positive. It recommends, however, that this medicine be contra-indicated in immobilised patients or patients with venous thromboembolism. It also updated the warnings regarding serious skin reactions.
The Committee for Medicinal Products for Human Use has reassessed the risk-benefit balance of medicines used in children against cough and cold, namely antitussives, expectorants and topical nasal decongestants. Based on the advice of this commission, the Federal Agency for Medicines and Health Products (FAMHP) has taken certain measures concerning these medicines.
New recommendations regarding the use of metoclopramide were issued, at the European level, following the observation of an increased frequency of adverse neurological events in children under 18 years: medicines containing metoclopramide are contraindicated in children less than one year and not recommended beyond one year and up to 18 years.
The FAMHP publishes information on advice committees that are established within it. Currently available information concerns the mission, the composition, the house rules and the agenda of the meetings of six committees. This information shall be supplemented regularly by the public agendas and minutes of the meetings of these committees as well as information on other committees set up within the FAMHP.
The new edition of the electronic newsletter "VIG-NEWS" of the Federal Agency for Medicines and Health Products (FAMHP) is now available. The VIG-NEWS is a selection of recent news concerning pharmacovigilance from different sources.